EVH Klasse A Evolent Health, Inc Class A Common Stock
NYSE · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 5, 2026 10-K/10-Q Aug 6, 2026
$3,54
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,1052-Wochen-Tief
$8,4652-Wochen-Hoch
P/E (TTM)
-0.8
EPS (TTM)
$-4.57
Umsatz (TTM)
$2.10B
Ihre Abzeichen
52W-Spanne
$2–$8
Analystenbewertung
BUY
Kursziel
$6
P/E
-0.8
ROE
-79.0%
Nettogewinnmarge
-24.1%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
EVH Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$3.54
P/E (TTM)
-0.8
EPS (TTM)
$-4.57
Umsatz (TTM)
$2.10B
ROE (TTM)
-79.0%
Verschuldungsgrad (MRQ)
2.5
52W-Spanne
$2–$8
EVH Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$1.88B2017-12-31 → 2025-12-31
EPS$-5.072017-12-31 → 2025-12-31
Freier Cashflow·2017-12-31 → 2019-12-31
Nettogewinnmarge-24.1%2018-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | EVH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -0.85-Jahres-Durchschnitt ≈-48.8 | ≈-48.8 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | EVH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -20.4%5-Jahres-Durchschnitt ≈-9.4% | ≈-9.4% | 2.7% | Schwach | |
| EBITDA-Marge (TTM) | -15.1%5-Jahres-Durchschnitt ≈-3.6% | ≈-3.6% | 4.3% | Schwach | |
| Vorgewinnmarge (TTM) | -23.9%5-Jahres-Durchschnitt ≈-11.4% | ≈-11.4% | -4.6% | Im Einklang | |
| Nettogewinnmarge (TTM) | -24.1%5-Jahres-Durchschnitt ≈-11.7% | ≈-11.7% | -3.9% | Im Einklang | |
| ROA (TTM) | -22.8%5-Jahres-Durchschnitt ≈-7.1% | ≈-7.1% | -2.6% | Schwach | |
| ROE (TTM) | -79.0%5-Jahres-Durchschnitt ≈-21.2% | ≈-21.2% | 2.4% | Schwach | |
| ROIC | -29.6%5-Jahres-Durchschnitt ≈-7.8% | ≈-7.8% | -14.9% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | EVH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 2.55-Jahres-Durchschnitt ≈0.9 | ≈0.9 | 0.1 | Hohe Verschuldung | |
| Liquiditätsgrad (MRQ) | 1.25-Jahres-Durchschnitt ≈1.1 | ≈1.1 | 1.5 | Unterdurchschnittlich | |
| Quick Ratio | 1.25-Jahres-Durchschnitt ≈1.0 | ≈1.0 | 1.0 | Im Einklang | |
| Langfristige Schulden / Eigenkapital (MRQ) | 2.55-Jahres-Durchschnitt ≈0.8 | ≈0.8 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | EVH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -26.6%5-Jahres-Durchschnitt ≈19.2% | ≈19.2% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 11.5%5-Jahres-Durchschnitt ≈27.1% | ≈27.1% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 15.2% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | EVH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.85-Jahres-Durchschnitt ≈0.8 | ≈0.8 | 0.6 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 5.25-Jahres-Durchschnitt ≈5.6 | ≈5.6 | 7.0 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$446.7K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-5.7%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 6, 2026 | $0.02 | $-0.02 | 183.7% |
| 31. März 2026 | $-0.02 | $-0.05 | 61.4% | |
| 31. Dezember 2025 | $0.08 | $0.06 | 37.7% | |
| 30. September 2025 | $0.05 | $0.11 | -52.6% | |
| 30. Juni 2025 | $-0.10 | $0.08 | -226.4% | |
| 31. März 2025 | $0.06 | $0.10 | -37.8% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.88B | $2.55B | $1.96B | $1.35B | $908M | $925M | $687M | $627M | $435M | $254M | |
| Cost of Revenue | $1.48B | $2.19B | $1.50B | $1.04B | $658M | · | · | · | · | · | |
| R&D Expense | · | · | · | · | $16M | $15M | $20M | $18M | $17M | $11M | |
| SG&A Expense | $304M | $263M | $358M | $269M | $219M | $210M | $236M | $235M | $206M | $161M | |
| Operating Expenses | $2.29B | $2.60B | $2.04B | $1.35B | $950M | $1.19B | $996M | $675M | $508M | $492M | |
| Operating Income | $-410M | $-40M | $-71M | $4M | $-42M | $-263M | $-309M | $-47M | $-73M | $-237M | |
| Interest Expense | · | · | $54M | $16M | $25M | $28M | $15M | $5M | $4M | $247.0K | |
| Interest Income | $4M | $6M | $5M | $1M | $407.0K | $3M | $3M | $3M | $2M | $970.0K | |
| Other Non-op | $249.0K | $241.0K | $-543.0K | $57.0K | $-146.0K | $-118.0K | $-489.0K | $109.0K | $171.0K | $4.0K | |
| Pretax Income | $-535M | $-63M | $-202M | $-62M | $-30M | $-331M | $-330M | $-54M | $-76M | $-238M | |
| Income Tax | $-126.0K | $-1M | $-89M | $-43M | $483.0K | $-2M | $-23M | $40.0K | $-7M | $-11M | |
| Net Income | $-535M | $-62M | $-113M | $-19M | $-38M | $-334M | $-306M | $-53M | $-61M | $-160M | |
| EPS (Basic) | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.44 | $-3.94 | $-3.67 | · | $-0.94 | $-3.55 | |
| EPS (Diluted) | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.44 | $-3.94 | $-3.67 | · | $-0.94 | $-3.55 | |
| Shares (Basic) | 114,208,000 | 114,682,000 | 111,251,000 | 93,699,000 | 86,067,000 | 84,928,000 | 82,364,000 | · | 64,351,000 | 45,031,000 | |
| Shares (Diluted) | 114,208,000 | 114,682,000 | 111,251,000 | 93,699,000 | 86,067,000 | 84,928,000 | 82,364,000 | · | 64,351,000 | 45,031,000 | |
| EBITDA | $-294M | $78M | $52M | $71M | $18M | $-209M | $-246M | $-3M | $-40M | $-220M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $152M | $104M | $193M | $188M | $266M | $319M | $101M | $228M | $238M | $135M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $0 | $44M | |
| Receivables | $310M | $415M | $447M | $255M | $131M | $124M | $76M | $80M | $49M | $41M | |
| Prepaid Expense | $19M | $29M | $30M | $21M | $51M | $56M | $28M | $23M | $8M | $11M | |
| Current Assets | $506M | $607M | $684M | $478M | $524M | $548M | $229M | $488M | $378M | $265M | |
| PP&E (Net) | $81M | $73M | $78M | $88M | $81M | $86M | $85M | $74M | $51M | $31M | |
| PP&E (Gross) | $287M | $253M | $237M | $238M | $200M | $175M | $140M | $105M | $65M | $36M | |
| Accum. Depreciation | $206M | $180M | $159M | $150M | $119M | $89M | $55M | $32M | $14M | $5M | |
| Goodwill | $694M | $1.14B | $1.12B | $723M | $426M | $349M | $566M | $768M | $628M | $627M | |
| Intangibles | $585M | $680M | $752M | $443M | $280M | $265M | $308M | $335M | $241M | $259M | |
| Other Non-current Assets | · | · | · | · | · | · | · | $15M | $9M | $10M | |
| Total Assets | $1.90B | $2.54B | $2.68B | $1.82B | $1.42B | $1.37B | $1.50B | $1.72B | $1.31B | $1.20B | |
| Accounts Payable | $60M | $96M | $48M | $57M | $96M | $32M | $37M | $147M | $43M | $44M | |
| Accrued Liabilities | $66M | $66M | $150M | $111M | $107M | $73M | $33M | $49M | $30M | $29M | |
| Short-term Debt | $0 | $171M | $0 | $0 | · | · | · | · | · | · | |
| Current Liabilities | $385M | $716M | $674M | $433M | $445M | $403M | $193M | $269M | $133M | $132M | |
| Capital Leases | $4M | $25M | $38M | $56M | $58M | $63M | $69M | $0 | · | · | |
| Deferred Tax | $8M | $11M | $13M | $5M | $1M | $679.0K | $2M | $25M | $2M | $21M | |
| Other Non-current Liabilities | $8M | $3M | $4M | $5M | $6M | $22M | $12M | $17M | $10M | $15M | |
| Total Liabilities | $1.48B | $1.35B | $1.43B | $958M | $726M | $752M | $569M | $533M | $266M | $288M | |
| Long-term Debt | · | · | · | · | $216M | $290M | $294M | $221M | $121M | $120M | |
| Total Debt | $971M | $662M | $597M | $413M | $216M | $290M | · | · | · | · | |
| Common Stock | $1M | $1M | $1M | $1M | $908.0K | $859.0K | · | · | · | · | |
| Paid-in Capital | $1.79B | $1.80B | $1.81B | $1.49B | $1.34B | $1.23B | $1.17B | $1.09B | $924M | $555M | |
| Retained Earnings | $-1.32B | $-781M | $-719M | $-606M | $-627M | $-589M | $-252M | $50M | $86M | $147M | |
| Treasury Stock | $61M | $21M | $21M | $21M | $21M | $21M | $0 | · | · | · | |
| AOCI | $-3M | $-2M | $-1M | $-1M | $-362.0K | $-278.0K | $-234.0K | $-182.0K | $0 | · | |
| Stockholders' Equity | $415M | $1.00B | $1.07B | $859M | $694M | $620M | $929M | $1.14B | $1.01B | $703M | |
| Liabilities + Equity | $1.90B | $2.54B | $2.68B | $1.82B | $1.42B | $1.37B | $1.50B | $1.72B | $1.31B | $1.20B | |
| Shares Outstanding | · | · | · | · | · | · | 84,588,629 | · | · | · |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $116M | $118M | $123M | $67M | $60M | $61M | $61M | $45M | $32M | $17M | |
| Stock-based Comp | $40M | $40M | $41M | $34M | $17M | $15M | $16M | $18M | $20M | $19M | |
| Deferred Tax | $-15M | $-19M | $-54M | $2M | $-10M | $-48M | $-32M | $-17M | $100.0K | $-11M | |
| Amort. of Intangibles | $90M | $88M | $91M | $35M | $29M | $32M | $37M | $27M | $23M | $12M | |
| Restructuring | · | · | · | $0 | $7M | $1M | $0 | $0 | · | · | |
| Other Non-cash | $433M | $-59M | $146M | $-96M | $10M | $290M | $215M | $-13M | $-20M | $99M | |
| Operating Cash Flow | $39M | $19M | $143M | $-12M | $39M | $-16M | $-43M | $-21M | $-28M | $-36M | |
| CapEx | · | · | · | · | · | · | $36M | $40M | $28M | $16M | |
| Investing Cash Flow | $-233.0K | $-63M | $-416M | $-259M | $-16M | $261M | $-182M | $-160M | $-12M | $-97M | |
| Debt Issued | · | · | $647M | $220M | $0 | $30M | · | · | · | · | |
| Net Debt Issued | · | $0 | $183M | $220M | · | · | · | · | · | · | |
| Stock Repurchased | $40M | $0 | $0 | · | · | · | · | · | · | · | |
| Net Stock Activity | $-40M | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-36M | $-565.0K | $281M | $132M | $-30M | $-12M | $-36M | $274M | $166M | $150M | |
| Net Change in Cash | $2M | $-45M | $8M | $-140M | $-7M | $233M | $-260M | $93M | $125M | $18M | |
| Taxes Paid | $3M | $1M | $5M | $1M | $551.0K | $10M | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | $-78M | $-60M | $-56M | $-51M | |
| Levered FCF | · | · | · | · | · | · | $-92M | $-66M | $-59M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -21.9% | -1.6% | · | · | -4.7% | -26.5% | -36.2% | -7.6% | · | -32838.0% | |
| Net Margin | -28.5% | -2.4% | · | · | -4.1% | -32.7% | -35.7% | -8.4% | · | -22094.3% | |
| Pretax Margin | -28.5% | -2.5% | · | · | -3.3% | -33.0% | -38.6% | -8.6% | · | -32853.8% | |
| EBITDA Margin | -15.7% | 3.0% | · | · | 1.9% | -20.5% | -29.0% | -0.47% | · | -30455.7% | |
| ROA | -24.1% | -2.4% | -5.0% | -1.2% | -2.8% | -23.3% | -18.8% | -3.5% | -4.8% | -14.4% | |
| ROE | -81.5% | -6.0% | -10.4% | -2.2% | -5.8% | -43.2% | -29.2% | -4.9% | -7.1% | -23.6% | |
| ROIC | -29.6% | -2.4% | -2.4% | 0.09% | -4.7% | -29.4% | -31.1% | -4.2% | -6.6% | -32.3% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 0.8 | 1.0 | 1.1 | 1.2 | 1.4 | 1.2 | 1.8 | 2.8 | 2.0 | |
| Quick Ratio | 1.2 | 0.7 | 0.9 | 1.0 | 0.9 | 1.2 | 0.9 | 1.1 | 2.2 | 1.7 | |
| Debt / Equity | 2.3 | 0.7 | 0.6 | 0.5 | 0.3 | 0.5 | · | · | · | · | |
| LT Debt / Equity | 2.3 | 0.5 | 0.6 | 0.5 | 0.3 | 0.4 | · | · | · | · | |
| Interest Coverage | · | · | -1.3 | 0.2 | -1.7 | -9.6 | -21.1 | -8.7 | -20.0 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 1.0 | · | · | 0.7 | 0.7 | 0.5 | 0.4 | · | 0.0 | |
| Receivables Turnover | 5.2 | 5.9 | · | · | 5.8 | 10.1 | 10.9 | 9.7 | · | 0.0 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $16.43 | $22.28 | · | · | $10.55 | · | · | · | · | $0.02 | |
| Cash Flow / Share | $0.34 | $0.16 | $1.28 | $-0.12 | $0.45 | · | · | · | $-0.43 | $-0.79 | |
| EPS (TTM) | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.44 | $-3.94 | $-3.67 | $-0.65 | $-0.94 | $-3.55 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -26.6% | 30.1% | 45.3% | 48.9% | -1.8% | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.5% | 41.2% | 28.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 15.2% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.88B | $2.55B | $1.96B | $1.35B | $908M | $925M | $687M | $627M | $435M | $254M | |
| Net Income TTM | $-535M | $-62M | $-113M | $-19M | $-38M | $-334M | $-306M | $-53M | $-61M | $-160M | |
| P/E | -0.8 | -13.9 | -25.8 | -140.4 | -62.9 | -4.1 | -2.5 | -30.7 | -13.1 | -4.2 | |
| Earnings Yield | -126.8% | -7.2% | -3.9% | -0.71% | -1.6% | -24.6% | -40.6% | -3.3% | -7.6% | -24.0% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $653M | $496M | $469M | $480M | $444M | $484M | $647M | $621M | $647M | $640M | $556M | $511M | $469M | $428M | $382M | $353M | |
| Cost of Revenue | $572M | $412M | $371M | $380M | $344M | $381M | $571M | $541M | $540M | $536M | $454M | $387M | $352M | $310M | $299M | $267M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| SG&A Expense | $69M | $73M | $73M | $78M | $75M | $78M | $48M | $67M | $69M | $79M | $81M | $97M | $90M | $90M | $83M | $69M | |
| Operating Expenses | $662M | $507M | $877M | $479M | $445M | $485M | $665M | $638M | $639M | $653M | $577M | $529M | $491M | $438M | $384M | $340M | |
| Operating Income | $-10M | $-11M | $-408M | $886.0K | $-1M | $-2M | $-19M | $-16M | $8M | $-13M | $-21M | $-18M | $-22M | $-10M | $-2M | $13M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $6M | · | $15M | $14M | $13M | · | $5M | |
| Interest Income | $703.0K | $1M | $868.0K | $964.0K | $1M | $1M | $830.0K | $794.0K | $1M | $3M | $3M | $1M | $604.0K | $1M | $604.0K | $425.0K | |
| Other Non-op | $109.0K | $742.0K | $252.0K | $80.0K | $-35.0K | $-48.0K | $381.0K | $-43.0K | $-105.0K | $8.0K | $-220.0K | $-77.0K | $-26.0K | $-220.0K | $-73.0K | $-345.0K | |
| Pretax Income | $-26M | $-26M | $-431M | $-20M | $-21M | $-63M | $-24M | $-24M | $1M | $-17M | $-48M | $-31M | $-35M | $-88M | $-10M | $-43M | |
| Income Tax | $3M | $910.0K | $-2M | $906.0K | $-825.0K | $1M | $-1M | $-619.0K | $-238.0K | $565.0K | $-15M | $-6M | $-970.0K | $-68M | $1M | $-46M | |
| Net Income | $-28M | $-27M | $-429M | $-21M | $-20M | $-65M | $-23M | $-23M | $2M | $-17M | $-33M | $-25M | $-34M | $-20M | $-11M | $2M | |
| EPS (Basic) | $-0.25 | $-0.24 | $-3.84 | $-0.24 | $-0.44 | $-0.63 | $-0.27 | $-0.27 | $-0.06 | $-0.22 | $-0.37 | $-0.30 | $-0.37 | $-0.24 | $-0.11 | $0.02 | |
| EPS (Diluted) | $-0.25 | $-0.24 | $-3.84 | $-0.24 | $-0.44 | $-0.63 | $-0.27 | $-0.27 | $-0.06 | $-0.22 | $-0.37 | $-0.30 | $-0.37 | $-0.24 | $-0.11 | $0.02 | |
| Shares (Basic) | 112,542,000 | 111,905,000 | · | 114,066,000 | 115,882,000 | 115,315,000 | · | 114,862,000 | 114,688,000 | 114,141,000 | · | 112,282,000 | 111,278,000 | 107,783,000 | · | 95,286,000 | |
| Shares (Diluted) | 112,542,000 | 111,905,000 | · | 114,066,000 | 115,882,000 | 115,315,000 | · | 114,862,000 | 114,688,000 | 114,141,000 | · | 112,282,000 | 111,278,000 | 107,783,000 | · | 99,308,000 | |
| EBITDA | $-10M | $11M | · | $886.0K | $-1M | $22M | · | $-16M | $8M | $16M | · | $-18M | $-22M | $19M | · | $13M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $116M | $142M | $152M | $117M | $151M | $247M | $104M | $97M | $101M | $165M | · | $185M | $143M | $158M | · | $157M | |
| Receivables | $449M | $314M | $310M | $387M | $359M | $430M | $415M | $408M | $374M | $428M | · | $394M | $345M | $263M | · | $188M | |
| Prepaid Expense | $23M | $22M | $19M | $22M | $28M | $35M | $29M | $23M | $26M | $25M | · | $37M | $41M | $34M | · | $24M | |
| Current Assets | $611M | $502M | $506M | $570M | $562M | $728M | $607M | $544M | $521M | $669M | · | $639M | $577M | $476M | · | $394M | |
| PP&E (Net) | $82M | $81M | $81M | $80M | $77M | $74M | $73M | $74M | $75M | $76M | · | $80M | $84M | $89M | · | $95M | |
| PP&E (Gross) | $298M | $293M | $287M | $280M | $271M | $261M | $253M | $247M | $241M | $234M | · | $255M | $250M | $247M | · | $236M | |
| Accum. Depreciation | $216M | $212M | $206M | $200M | $193M | $187M | $180M | $173M | $166M | $158M | · | $175M | $167M | $159M | · | $142M | |
| Goodwill | $694M | $694M | $694M | $1.08B | $1.14B | $1.14B | $1.14B | $1.14B | $1.12B | $1.12B | $1.12B | $1.12B | $1.12B | $1.12B | $723M | $723M | |
| Intangibles | $554M | $570M | $585M | $624M | $651M | $668M | $680M | $697M | $711M | $731M | · | $778M | $802M | $826M | · | $451M | |
| Total Assets | $1.97B | $1.88B | $1.90B | $2.45B | $2.46B | $2.65B | $2.54B | $2.50B | $2.48B | $2.64B | · | $2.67B | $2.65B | $2.59B | · | $1.76B | |
| Accounts Payable | $39M | $63M | $60M | $72M | $69M | $58M | $96M | $50M | $39M | $77M | · | $52M | $77M | $51M | · | $62M | |
| Accrued Liabilities | $44M | $45M | $66M | $61M | $64M | $100M | $66M | $120M | $85M | $165M | · | $194M | $167M | $170M | · | $132M | |
| Short-term Debt | · | · | $0 | $5M | $172M | $172M | $171M | · | · | · | · | $991.0K | · | · | · | · | |
| Current Liabilities | $493M | $381M | $385M | $430M | $558M | $739M | $716M | $524M | $483M | $659M | · | $615M | $541M | $458M | · | $382M | |
| Capital Leases | $2M | $3M | $4M | $4M | $8M | $16M | $25M | $29M | $31M | $32M | · | $40M | $57M | $54M | · | $58M | |
| Deferred Tax | $10M | $8M | $8M | $10M | $10M | $11M | $11M | $12M | $13M | $13M | · | $27M | $34M | $36M | · | $4M | |
| Other Non-current Liabilities | $8M | $8M | $8M | $4M | $4M | $3M | $3M | $3M | $3M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Total Liabilities | $1.59B | $1.48B | $1.48B | $1.61B | $1.34B | $1.52B | $1.35B | $1.28B | $1.24B | $1.41B | · | $1.40B | $1.38B | $1.30B | · | $903M | |
| Total Debt | $966M | $973M | · | $1.06B | $821M | $819M | · | $600M | $599M | $598M | · | $601M | $633M | $632M | · | $412M | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Paid-in Capital | $1.82B | $1.80B | $1.79B | $1.79B | $1.78B | $1.80B | $1.80B | $1.82B | $1.81B | $1.81B | · | $1.80B | $1.77B | $1.77B | · | $1.47B | |
| Retained Earnings | $-1.37B | $-1.34B | $-1.32B | $-886M | $-865M | $-845M | $-781M | $-758M | $-735M | $-736M | · | $-686M | $-660M | $-626M | · | $-595M | |
| Treasury Stock | $61M | $61M | $61M | $61M | $21M | $21M | $21M | $21M | $21M | $21M | · | $21M | $21M | $21M | · | $21M | |
| AOCI | $-4M | $-4M | $-3M | $-2M | $-2M | $-2M | $-2M | $-1M | $-1M | $-1M | · | $-1M | $-1M | $-1M | · | $-1M | |
| Stockholders' Equity | $383M | $396M | $415M | $842M | $896M | $936M | $1.00B | $1.04B | $1.05B | $1.05B | $1.07B | $1.10B | $1.09B | $1.12B | $859M | $856M | |
| Liabilities + Equity | $1.97B | $1.88B | $1.90B | $2.45B | $2.46B | $2.65B | $2.54B | $2.50B | $2.48B | $2.64B | · | $2.67B | $2.65B | $2.59B | · | $1.76B |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $22M | $45M | $24M | $23M | $24M | $29M | $30M | $30M | $30M | $30M | $32M | $32M | $29M | $20M | $17M | |
| Stock-based Comp | $15M | $11M | $2M | $15M | $12M | $11M | $-6M | $14M | $13M | $19M | $11M | $10M | $9M | $11M | $15M | $7M | |
| Amort. of Intangibles | $15M | $15M | $39M | $17M | $17M | $17M | $22M | $22M | $22M | $22M | $22M | $24M | $24M | $21M | $11M | $10M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Other Non-cash | · | $-7M | · | · | · | $34M | · | · | · | $-26M | · | · | · | $-22M | · | · | |
| Operating Cash Flow | $-9M | $-984.0K | $49M | $16M | $-30M | $5M | $-26M | $19M | $21M | $5M | $89M | $61M | $654.0K | $-8M | $36M | $-3M | |
| Investing Cash Flow | $-7M | $-6M | $82M | $-9M | $-61M | $-13M | $-20M | $-20M | $-14M | $-10M | $-6M | $-6M | $-8M | $-395M | $-4M | $-255M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $-267.0K | $256M | · | $220M | |
| Net Debt Issued | · | · | · | · | · | $-62M | · | · | · | $0 | · | · | · | $219M | · | · | |
| Stock Repurchased | · | · | $0 | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-11M | $-4M | $-93M | $-42M | $-9M | $108M | $97M | $-9M | $-103M | $15M | $-84M | $-37M | $23M | $380M | $-11M | $173M | |
| Net Change in Cash | $-27M | $-12M | $38M | $-35M | $-100M | $99M | $51M | $-10M | $-96M | $10M | $-1M | $17M | $16M | $-23M | $20M | $-86M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1.5% | -2.1% | · | 0.18% | -0.26% | -0.34% | · | -2.6% | 1.2% | -2.1% | · | -3.5% | -4.6% | -2.4% | · | 3.7% | |
| Net Margin | -4.3% | -5.4% | · | -4.3% | -4.5% | -13.4% | · | -3.7% | 0.25% | -2.7% | · | -5.0% | -7.3% | -6.1% | · | 0.60% | |
| Pretax Margin | -3.9% | -5.2% | · | -4.2% | -4.7% | -13.1% | · | -3.8% | 0.21% | -2.6% | · | -6.0% | -7.5% | -20.6% | · | -12.3% | |
| EBITDA Margin | -1.5% | 2.2% | · | 0.18% | -0.26% | 4.6% | · | -2.6% | 1.2% | 2.5% | · | -3.5% | -4.6% | 4.4% | · | 3.7% | |
| ROA | -1.3% | -1.2% | · | -0.84% | -0.81% | -2.4% | · | -0.89% | 0.06% | -0.66% | · | -1.1% | -1.7% | -1.3% | · | 0.14% | |
| ROE | -4.4% | -4.0% | · | -2.2% | -2.0% | -6.5% | · | -2.2% | 0.15% | -1.6% | · | -2.6% | -4.0% | -3.0% | · | 0.29% | |
| ROIC | -0.78% | -0.80% | · | 0.05% | -0.07% | -0.09% | · | -0.97% | 0.55% | -0.84% | · | -0.87% | -1.2% | -0.13% | · | -0.05% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.3 | · | 1.3 | 1.0 | 1.0 | · | 1.0 | 1.1 | 1.0 | · | 1.0 | 1.1 | 1.0 | · | 1.0 | |
| Quick Ratio | 1.1 | 1.2 | · | 1.2 | 0.9 | 0.9 | · | 1.0 | 1.0 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | |
| Debt / Equity | 2.5 | 2.5 | · | 1.3 | 0.9 | 0.9 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.5 | |
| LT Debt / Equity | 2.5 | 2.5 | · | 1.3 | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -2.2 | · | -1.2 | -1.5 | -0.8 | · | 2.7 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.6 | 1.3 | · | 1.2 | 1.2 | 1.1 | · | 1.5 | 1.8 | 1.9 | · | 1.8 | 2.0 | 1.9 | · | 1.9 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $5.80 | $4.43 | · | $4.20 | $3.83 | $4.19 | · | $5.41 | $5.64 | $5.60 | · | $4.55 | $4.22 | $3.97 | · | $3.55 | |
| Cash Flow / Share | · | $-0.01 | · | · | · | $0.04 | · | · | · | $0.04 | · | · | · | $-0.07 | · | · | |
| EPS (TTM) | $-4.57 | $-4.76 | · | $-1.58 | $-1.61 | $-1.23 | · | $-0.92 | $-0.95 | $-1.26 | · | $-1.02 | $-0.70 | $-0.38 | · | $-0.15 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.10B | $1.89B | · | $2.05B | $2.20B | $2.40B | · | $2.46B | $2.35B | $2.18B | · | $1.79B | $1.63B | $1.48B | · | $1.22B | |
| Net Income TTM | $-505M | $-497M | · | $-128M | $-130M | $-109M | · | $-72M | $-74M | $-110M | · | $-91M | $-64M | $-34M | · | $-13M | |
| P/E | -1.2 | -0.5 | · | -5.4 | -7.0 | -7.7 | · | -30.7 | -20.1 | -26.0 | · | -26.7 | -43.3 | -85.4 | · | -239.5 | |
| Earnings Yield | -84.3% | -208.8% | · | -18.7% | -14.3% | -13.0% | · | -3.2% | -5.0% | -3.8% | · | -3.8% | -2.3% | -1.2% | · | -0.42% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $1.88B | $2.55B | $1.96B | $1.35B | $908M |
| Betriebsgewinnmarge % | -21.9% | -1.6% | · | · | -4.7% |
| Nettoergebnis | $-535M | $-62M | $-113M | $-19M | $-38M |
| Verwässerte EPS | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.44 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 2.3 | 0.7 | 0.6 | 0.5 | 0.3 |
| Liquiditätsgrad | 1.3 | 0.8 | 1.0 | 1.1 | 1.2 |
| Quick Ratio | 1.2 | 0.7 | 0.9 | 1.0 | 0.9 |
Keine Daten für diese Aufstellung
Noch nicht genügend Fundamentaldaten vorhanden, um diese Aufstellung zu erstellen.
Institutionelle Eigentümer (13F) 217 Einreicher · $665.3M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
217
Gehaltener Wert
$665.3M
Neue Positionen
36
Geschlossene Positionen
29
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 36 (-7 vs. Vorquartal) | 29 (-24 vs. Vorquartal) | 72 (+13 vs. Vorquartal) | 64 (+2 vs. Vorquartal) | +1.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $80.296.492 | 14.814.851 | 12,07% | Aktien |
| CADIAN CAPITAL MANAGEMENT, LP | $58.614.444 | 10.814.473 | 8,81% | Aktien |
| MORGAN STANLEY | $48.612.048 | 8.969.012 | 7,31% | Aktien |
| VANGUARD GROUP INC | $35.656.260 | 8.914.065 | 5,36% | Aktien |
| UBS Group AG | $33.849.434 | 6.245.283 | 5,09% | Aktien |
| Rubicon Founders LLC | $31.523.387 | 5.816.123 | 4,74% | Aktien |
| Engaged Capital LLC | $30.156.403 | 5.563.912 | 4,53% | Aktien |
| D. E. Shaw & Co., Inc. | $27.682.981 | 5.107.561 | 4,16% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $25.950.927 | 4.787.994 | 3,90% | Aktien |
| MARSHALL WACE, LLP | $18.499.786 | 3.413.245 | 2,78% | Aktien |
| Nuveen, LLC | $16.975.900 | 3.132.085 | 2,55% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $15.748.879 | 2.904.912 | 2,37% | Aktien |
| Rock Springs Capital Management LP | $13.550.000 | 2.500.000 | 2,04% | Aktien |
| STATE STREET CORP | $13.335.536 | 2.460.431 | 2,00% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11.553.126 | 2.131.573 | 1,74% | Aktien |
| Glenmede Investment Management, LP | $10.477.514 | 1.238.477 | 1,57% | Aktien |
| Camber Capital Management LP | $9.571.000 | 850.000 | 1,44% | Aktien |
| GOLDMAN SACHS GROUP INC | $9.462.518 | 1.745.852 | 1,42% | Aktien |
| Rock Point Advisors, LLC | $9.321.782 | 1.719.886 | 1,40% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $8.680.878 | 1.601.638 | 1,30% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $8.497.563 | 1.567.816 | 1,28% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7.305.195 | 1.347.822 | 1,10% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $6.920.256 | 1.276.800 | 1,04% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $6.848.999 | 1.263.653 | 1,03% | Aktien |
| NORTHERN TRUST CORP | $5.437.589 | 1.003.245 | 0,82% | Aktien |
| Hudson Bay Capital Management LP | $4.949.051 | 913.109 | 0,74% | Aktien |
| BANK OF AMERICA CORP /DE/ | $4.744.657 | 875.398 | 0,71% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $4.663.140 | 860.358 | 0,70% | Aktien |
| Walleye Capital LLC | $4.584.166 | 845.787 | 0,69% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $4.296.803 | 792.768 | 0,65% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $4.149.028 | 765.020 | 0,62% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $4.132.002 | 762.362 | 0,62% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $3.790.027 | 699.267 | 0,57% | Aktien |
| Voleon Capital Management LP | $3.612.441 | 666.502 | 0,54% | Aktien |
| Cubist Systematic Strategies, LLC | $3.564.938 | 421.387 | 0,54% | Aktien |
| ALGERT GLOBAL LLC | $3.558.029 | 656.463 | 0,53% | Aktien |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $3.414.600 | 630.000 | 0,51% | Aktien |
| Man Group plc | $2.700.634 | 498.272 | 0,41% | Aktien |
| CITADEL ADVISORS LLC | $2.649.372 | 488.814 | 0,40% | Aktien |
| FORMULA GROWTH LTD | $2.628.700 | 485.000 | 0,40% | Aktien |
| CITIGROUP INC | $2.521.091 | 465.146 | 0,38% | Aktien |
| Tejara Capital Ltd | $2.392.692 | 441.456 | 0,36% | Aktien |
| Invesco Ltd. | $2.247.036 | 414.582 | 0,34% | Aktien |
| Jump Financial, LLC | $2.103.448 | 388.090 | 0,32% | Aktien |
| Mariner, LLC | $2.015.099 | 371.753 | 0,30% | Aktien |
| Benefit Street Partners LLC | $1.968.354 | 363.165 | 0,30% | Aktien |
| Bank of New York Mellon Corp | $1.867.883 | 344.628 | 0,28% | Aktien |
| Creative Planning | $1.788.692 | 330.017 | 0,27% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $1.644.119 | 303.343 | 0,25% | Aktien |
| BRIGHTON JONES LLC | $1.593.998 | 294.096 | 0,24% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Engaged Capital Flagship Master Fund, LP, Engaged Capital Co-Invest XI, LP, Engaged Capital Flagship Fund, LP, Engaged Capital Flagship Fund, Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling ×6 Einreichungen | 25. August 2022 | · | Erste Einreichung | · | SEC |
| UnitedHealth Group Incorporated, The Advisory Board Company ×2 Einreichungen | 5. März 2018 | · | Erste Einreichung | Vorstandskampagne | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 37 Insider · 15 Führungskräfte · 21 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Seth Blackley | Chief Executive Officer | 1. Juli 2026 F | 1.272.767 | 0 | 0 | $0 |
| Steve Wigginton | CEO, Valence Health | 1. August 2017 M | 12.411 | 0 | 0 | $0 |
| Mario Ramos | Chief Financial Officer | 2. März 2026 A | 587.500 | 0 | 0 | $0 |
| John Paul Johnson | Chief Financial Officer | 1. Juli 2025 A | 309.245 | 0 | 0 | $0 |
| Nicholas Mcgrane | Chief Financial Officer | 1. März 2019 A | 84.088 | 0 | 0 | $0 |
| Daniel Joseph Mccarthy | PRESIDENT | 26. August 2026 S | 655.133 | 0 | 1 | $-329.460 |
| Emily Ann Rafferty | Chief Operating Officer | 3. März 2025 F | 130.128 | 0 | 0 | $0 |
| Steve Tutewohl | Chief Operating Officer | 1. Juli 2023 A | 136.331 | 0 | 0 | $0 |
| Thomas Peterson III | Chief Operating Officer | 1. März 2019 A | 67.868 | 0 | 0 | $0 |
| Aammaad Shams | Chief Accounting Officer | 1. Juli 2026 A | 95.637 | 0 | 0 | $0 |
| Jonathan Weinberg | General Counsel | 1. Juli 2026 F | 284.917 | 0 | 0 | $0 |
| Lydia Stone | Chief Accounting Officer | 2. März 2020 A | 48.855 | 0 | 0 | $0 |
| Dave Thornton | Chief Talent Officer | 14. September 2016 S | 95.457 | 0 | 0 | $0 |
| Chad Pomeroy | Chief Technology Officer | 14. September 2016 S | 286.370 | 0 | 0 | $0 |
| Gary Piefer | Chief Medical Officer | 10. Juni 2015 P | 206.269 | 0 | 0 | $0 |
| Russell Monroe Glass | Direktor | 4. Juni 2026 A | 77.347 | 0 | 0 | $0 |
| Toyin Ajayi | Direktor | 4. Juni 2026 A | 75.170 | 0 | 0 | $0 |
| Kim Keck | Direktor | 4. Juni 2026 A | 102.597 | 0 | 0 | $0 |
| Richard M Jelinek | Direktor | 4. Juni 2026 A | 77.533 | 0 | 0 | $0 |
| Brendan B Springstubb | Direktor | 4. Juni 2026 A | 99.917 | 1 | 0 | $38.200 |
| Craig A. Barbarosh | Direktor | 4. Juni 2026 A | 95.031 | 0 | 0 | $0 |
| Jill D. Smith | Direktor | 4. Juni 2026 A | 64.233 | 0 | 0 | $0 |
| Peter J Grua | Direktor | 4. Juni 2026 A | 63.075 | 0 | 0 | $0 |
| Shawn M Guertin | Direktor | 4. Juni 2026 A | 63.075 | 0 | 0 | $0 |
| Cheryl Scott | Direktor | 5. Juni 2025 A | 73.476 | 0 | 0 | $0 |
| Diane Holder | Direktor | 6. März 2025 P | 70.584 | 0 | 0 | $0 |
| Mary Bridget Duffy | Direktor | 6. Juni 2024 A | 48.001 | 0 | 0 | $0 |
| Tunde Sotunde | Direktor | 8. Juni 2023 A | 14.018 | 0 | 0 | $0 |
| Frank J Williams | Direktor | 1. Juni 2023 M | 819.812 | 0 | 0 | $0 |
| David Farner | Direktor | 9. Juni 2022 A | 67.091 | 0 | 0 | $0 |
| Michael D'Amato | Direktor | 10. Juni 2021 A | 93.455 | 0 | 0 | $0 |
| Bruce C. Felt Jr. | Direktor | 9. Juni 2020 A | 53.742 | 0 | 0 | $0 |
| Kenneth A Samet | Direktor | 15. August 2019 P | 39.235 | 0 | 0 | $0 |
| Norman Payson | Direktor | 13. Juni 2018 A | 21.284 | 0 | 0 | $0 |
| UNITEDHEALTH GROUP INC | Direktor | 1. Juni 2018 S | 0 | 0 | 0 | $0 |
| UPMC | 10%-Eigentümer | 19. Mai 2017 S | 6.434.283 | 0 | 0 | $0 |
| ADVISORY BOARD CO | 10%-Eigentümer | 19. Mai 2017 C | 4.128.167 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 21 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| JSML · Janus Detroit Street Trust | 0,30% | 353.725 NS | 31. Juli 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0,24% | 814.328 NS | 31. Juli 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,18% | 287.524 SH | 19. August 2026 | Täglich |
| IHF · iShares Trust | 0,07% | 217.647 SH | 11. September 2026 | Täglich |
| HAPS · Harbor ETF Trust | 0,06% | 32.306 NS | 31. Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 376.452 SH | 2. Oktober 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 64.467 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 659.586 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,02% | 2.931.653 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 54.743 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 381.420 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.299.653 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 43.642 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 283.197 SH | 19. August 2026 | Täglich |
| DFSV · Dimensional ETF Trust | 0,00% | 111.300 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 142.347 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 29.771 SH | 3. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 7.074 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.384.855 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.406 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 683.840 SH | 11. September 2026 | Täglich |
EVH Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 19 Analysten
KAUF
Median-Ziel
$6.00
+69,7%
5 26,3%
Starker Kauf
10 52,6%
Kauf
4 21,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
12 Analysten · 2026-09-29Mittelwert-Ziel $5.75 +62,7%
Jetzt
Aktueller Preis $3.54
Tief$3.00
Mittelwert$5.75
Hoch$8.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| EVH | · | -0.8 | -26.6% | -28.5% | -81.5% | · |
| TDOC | $1.25B | -6.1 | -1.5% | -7.9% | -14.3% | · |
| HSTM | $682M | 37.8 | 4.3% | 6.0% | 5.2% | · |
| PHR | · | 335.8 | 14.5% | 0.48% | 0.73% | · |
| CTEV | $708M | -2.5 | 3.7% | -29.4% | 265.9% | · |
| SLP | $285M | -4.4 | 13.1% | -81.7% | -41.2% | 58.4% |
| AMWL | $81M | -0.8 | -2.0% | -38.4% | -35.4% | · |
| OPRX | $230M | 45.4 | 18.8% | 4.7% | 4.2% | 67.2% |
| DH | · | -2.2 | -4.2% | -57.5% | -28.2% | 75.9% |
| VEEV | $33.40B | 37.5 | 16.3% | 28.4% | 13.1% | 75.5% |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026